Over the past decade, however, a wave of technological advances has begun to expand the druggable proteome. These include covalent inhibitors (such as sotorasib), chemical proteomics, and AI-enabled ...

TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM ESTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...

I have always been a bit of a skeptic about how important AI will be for the biotechnology industry, but, given a few […] ...

A team of UC Santa Barbara engineering and molecular biology graduate students has developed software to accelerate the discovery process for therapies aimed at treating Alzheimer’s and other diseases ...

Abstract: Drug–drug interactions (DDIs) refer to the change in efficacy when two or more drugs taken at the same time. Reasonable DDI can enhance efficacy or reduce adverse drug reactions; otherwise, ...

Abstract: Drug–drug interaction (DDI) prediction is essential for drug development and clinical safety. Early studies mainly relied on large labeled datasets and focused on structural or sequential ...